Association of Cough Severity with Asthma Control and Quality of Life in Patients with Severe Asthma
- PMID: 38847887
- DOI: 10.1007/s00408-024-00710-5
Association of Cough Severity with Asthma Control and Quality of Life in Patients with Severe Asthma
Abstract
Purpose: Symptoms are important components in determining asthma control and in the adjustment of treatment levels. However, clinical relevance of cough in severe asthma is not well-understood. This study aimed to evaluate the severity and association of cough with patient-reported outcomes (PROs) in patients with severe asthma.
Methods: This study analyzed cross-sectional data from the Korean Severe Asthma Registry. The severity of coughing and wheezing symptoms was assessed using a Visual Analog Scale (VAS) ranging from 0 to 100 for each symptom. Additionally, PROs included the Asthma Control Test (ACT), the Severe Asthma Questionnaire (SAQ), and the EuroQoL 5-Dimension (EQ-5D) index. Multivariate linear regression analysis was employed to explore the relationship between cough severity and other PRO scores.
Results: A total of 498 patients with severe asthma (age: 57.9 ± 13.1 years, females: 60.2%) were analyzed. The cough VAS score was higher than the wheeze score (median 30, [interquartile range 10-50] vs. 20 [0-50]; P < 0.001). Additionally, 22.5% of patients ranked in a higher tertile for cough severity compared to wheezing, while 18.5% ranked higher for wheezing severity than cough. Significant correlations were observed between cough and wheeze VAS scores (r = 0.61, P < 0.05) and between each symptom's VAS score and the SAQ (cough: r = -0.41, P < 0.001; wheeze: r = -0.52, P < 0.001), ACT scores (cough: r = -0.50, P < 0.001; wheeze: r = -0.63, P < 0.001) and EQ-5D index (cough: r = -0.40, P < 0.001; wheeze: r = -0.45, P < 0.001). In univariate regression analysis, the cough VAS score had weaker descriptive power (R2) values than the wheeze VAS score in relation to the PRO measures. Nevertheless, cough severity remained significantly associated with ACT, SAQ scores and EQ-5D index in multivariate analyses adjusted for wheeze severity and other confounders.
Conclusion: Cough frequently presents as a severe symptom in patients with severe asthma and could have distinct impact on asthma control and quality of life.
Keywords: Asthma; Cough; Patient reported outcome measures.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis.J Allergy Clin Immunol Pract. 2025 Mar;13(3):533-541.e3. doi: 10.1016/j.jaip.2025.01.006. Epub 2025 Jan 10. J Allergy Clin Immunol Pract. 2025. PMID: 39800057
-
Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough.Respir Investig. 2024 Nov;62(6):987-994. doi: 10.1016/j.resinv.2024.08.005. Epub 2024 Aug 27. Respir Investig. 2024. PMID: 39197381
-
Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.Rheumatol Int. 2016 Apr;36(4):505-13. doi: 10.1007/s00296-016-3427-1. Epub 2016 Feb 6. Rheumatol Int. 2016. PMID: 26849891
-
Interrupting the cough reflex in asthma.Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):77-81. doi: 10.1097/ACI.0b013e328334e75f. Curr Opin Allergy Clin Immunol. 2010. PMID: 19996740 Review.
-
Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature.Lung. 2022 Apr;200(2):169-178. doi: 10.1007/s00408-022-00527-0. Epub 2022 Apr 13. Lung. 2022. PMID: 35416544 Free PMC article.
Cited by
-
LUNG Year in Review: 2024.Lung. 2025 Jan 22;203(1):29. doi: 10.1007/s00408-025-00785-8. Lung. 2025. PMID: 39841240 No abstract available.
References
-
- Global initiative for Asthma: Global strategy for the diagnosis, management and prevention strategy document: Updated 2023. Available from: https://ginasthma.org/ , Assessed 02 Oct 2023.
-
- Martinez-Rivera C, Crespo A, Pinedo-Sierra C, Garcia-Rivero JL, Pallares-Sanmartin A, Marina-Malanda N, Pascual-Erquicia S, Padilla A, Mayoralas-Alises S, Plaza V, Lopez-Vina A, Picado C (2018) Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations. Respir Med 135:22–28 - DOI - PubMed
-
- Louis G, Schleich F, Guillaume M, Kirkove D, Nekoee Zahrei H, Donneau AF, Henket M, Paulus V, Guissard F, Louis R, Petre B (2023) Development and validation of a predictive model combining patient-reported outcome measures, spirometry and exhaled nitric oxide fraction for asthma diagnosis. ERJ Open Res 9(1):00451-2022 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous